Eledon Pharmaceuticals paid its 3 named executives $6.5M in total in FY2025 (Dec). CEO David-Alexandre C. Gros, M.D. was paid $3.2M of that.
Pay$100 in the stock at the end of FY21 → $34
Pay of each named executive
David-Alexandre C. Gros, M.D.Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Steven Perrin, Ph.D.President and Chief Scientific Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Paul LittleChief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.